12-Jan-2012 - Clinigen and PCAS have inked a long term supply pact for the production of the API for Foscavir.
12-Jan-2012 - US scientists say a new N-heterocycles synthesis method could open door to the production of novel antibiotics, cancer and pain drugs.
11-Jan-2012 - Amarin plans to add a fourth API maker to its supply chain as it prepares for a potential launch of its triglyceride lowering therapy, AMR101, in the US in 2012.
11-Jan-2012 - Ashland says it will ramp up production of the tablet disintegrant and dissolution aid polyvinylpyrrolidone (PVPP) to meet growing drug industry demand.
10-Jan-2012 - Zhongxi Sunve has bought a stake in a Chinese oncology API manufacturer and has further takeovers in the pipeline.
09-Jan-2012 - Rousselot says its acquisition of Eastman Kodak’s Gel Corporation will boost its gelatine production capacity and help it meet soaring drug industry demand.
09-Jan-2012 - The USP has published draft supply chain integrity guidance outlining steps to stop counterfeit or adulterated drugs reaching patients.
05-Jan-2012 - Gulf Pharmaceutical Industries is set to become the first insulin maker in the Middle East with its new $136m plant in Ras Al Khaimah, UAE.
04-Jan-2012 - Supply chain security group Rx-360 has warned that guar gum – a thickening agent that is widely used in the drug industry – is in short supply.
04-Jan-2012 - The FDA should encourage industry to submit draft guidance to speed regulatory development, an agency working group found.
04-Jan-2012 - The Indian pharmaceutical industry faces “intense competition” from China as it tries to grow exports to $25bn, the country's commerce minister said.
03-Jan-2012 - The European Commission (EC) has set out its plans for ‘equivalence assessments’ for manufacturers in countries seeking to export APIs to Europe.
22-Dec-2011 - The US FDA is seeking information to help it protect celiac disease patients from pharma ingredients derived from wheat, barley, or rye.
21-Dec-2011 - It’s been a busy year for API (active pharmaceutical ingredient) manufacturers with new facilities, cost pressures and regulatory developments all hitting the headlines. And it seems recent developments in HPAPIs (high potency APIs) have caused a stir with news of the industry taking up the top 4 places of our end-of-year run-down. Here are the most read API stories from in-PharmaTechnologist in 2011…
20-Dec-2011 - China will keep its position as a leading API and intermediates supplier thanks to recovering global demand and the growth of the generic sector say market analysts.
20-Dec-2011 - Counterfeit anti-malarials containing the Viagra API were probably manufactured in Southeast Asia, researchers found.
19-Dec-2011 - BASF has raised its prices for three ethanolamines (EOA), key intermediates in the production of a wide range of active pharmaceutical ingredients (API).
15-Dec-2011 - Seppic has seen a boom in demand for its new natural origin coating agents for pharmaceuticals, which can speed up production time by 50 per cent at lab stage.
15-Dec-2011 - AMPAC posted a fourth quarter loss as process improvement difficulties offset rising demand for CNS and oncology ingredients.
12-Dec-2011 - Chemicals firm Vertellus Specialties has begun manufacturing operations at a new facility in China, citing growth of the country’s cyanopyridines market as the key driver for the investment.
08-Dec-2011 - Mettler Toledo says its new dissolved oxygen (DO) measuring optical sensors can speed up the API production process and reduce maintenance costs.
05-Dec-2011 - The US FDA has published draft guidance to help companies submit marketing applications for API-excipient co-crystals.
01-Dec-2011 - India-based Vivimed Labs is buying Uquifa for £35m ($55m) to add API capabilities in Europe and Latin America.
30-Nov-2011 - Ideal Cures says its new Instacoat E Series film can cut tablet coating times in half and save manufacturers money.
30-Nov-2011 - Taste masking plays a vital role in treatment compliance according to Cargill, which has launched a new flavour technology that it claims can make drugs more pleasant to take and help manufacturers save money.